#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5116577	B	Agonist activity at Kv7.2 (unknown origin) assessed as shifting of voltage dependent activation to more negative potentials by SyncroPatch assay	Homo sapiens	7		single protein format	Scientific Literature
2.	ALA5116578	B	Agonist activity at Kv7.2 (unknown origin) assessed as shifting of voltage dependent activation to more negative potentials at 5 uM by SyncroPatch assay	Homo sapiens	22		single protein format	Scientific Literature
3.	ALA5116579	B	Agonist activity at Kv7.2 W236L mutant (unknown origin) assessed as shifting of voltage dependent activation to more negative potentials at 5 uM by SyncroPatch assay	Homo sapiens	22		assay format	Scientific Literature
4.	ALA5116580	B	Agonist activity at Kv7.2 (unknown origin) assessed as shifting of voltage dependent activation to more negative potentials by SyncroPatch assay relative to control	Homo sapiens	7		single protein format	Scientific Literature
5.	ALA5116581	B	Agonist activity at Kv7.2 W236L mutant (unknown origin) assessed as shifting of voltage dependent activation to more negative potentials by SyncroPatch assay relative to control	Homo sapiens	7		assay format	Scientific Literature
6.	ALA5116582	B	Agonist activity at Kv7.2/3 (unknown origin) expressed in CHO cells co-expressing GFP	Homo sapiens	4		cell-based format	Scientific Literature
7.	ALA5116583	B	Agonist activity at Kv7.4 (unknown origin) expressed in CHO cells co-expressing GFP	Homo sapiens	4		cell-based format	Scientific Literature
8.	ALA5116584	B	Agonist activity at Kv7.5 (unknown origin) expressed in CHO cells co-expressing GFP	Homo sapiens	4		cell-based format	Scientific Literature
9.	ALA5116585	B	Potency index, ratio of EC50 for retigabine to EC50 for test compound for agonist activity at Kv7.2 (unknown origin) assessed as shifting of voltage dependent activation to more negative potentials by SyncroPatch assay	Homo sapiens	1		single protein format	Scientific Literature